On Air Now

Upcoming Shows

Program Schedule »

Tune in to Listen

1440 AM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
36° Feels Like: 27°
Wind: SE 14 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Snow Showers/Wind 41°

Tonight

Showers 36°

Tomorrow

Cloudy 46°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

Actelion buys U.S.-based firm with cancer drug in development

A general view shows Swiss biotech group Actelion Headquarters in Allschwil near Basel, April 23, 2011. REUTERS/Christian Hartmann
A general view shows Swiss biotech group Actelion Headquarters in Allschwil near Basel, April 23, 2011. REUTERS/Christian Hartmann

ZURICH (Reuters) - Actelion said it will acquire Ceptaris, a privately held U.S.-based specialty pharmaceutical company developing a topical drug, Valchlor, to treat a form of cancer.

Allschwil-based Actelion said it already paid Ceptaris $25 million and will pay another $225 million when the deal closes. The deal is contingent on Valchlor clinching approval from the U.S. health regulator.

"We expect the transaction to become cash-accretive before the end of 2014," Actelion executive Nicholas Franco said in a statement on Wednesday.

(Reporting By Katharina Bart)

Comments